Abstract
By stimulating hepatic glucose production, glucagon (released by islet α-cells) restores normal blood glucose levels when they fall below the normal range. We used optogenetics in conjunction with electrophysiology, cytoplasmic free Ca2+ concentration imaging, and hormone release measurements to explore the intrinsic and paracrine regulation of glucagon secretion. Many α-cells were spontaneously active at 1 mmol/L glucose. However, up to ∼50% of the α-cells were electrically silent. KATP channel blockade, amino acids, and somatostatin receptor antagonism restored electrical activity in such α-cells. Termination of optoactivation resulted in KATP channel–dependent (tolbutamide sensitive) membrane repolarization in active α-cells but long-lasting membrane depolarization and action potential firing in silent α-cells. The latter effect was associated with an increased cytoplasmic ATP:ADP ratio. Optoactivation or optoinhibition of somatostatin-releasing δ-cells inhibits and stimulates electrical activity in adjacent (but not distal) α-cells. There is an inverse relationship between basal glucagon secretion (a measure of the fraction active α-cells) and the relative stimulatory effects of amino acids. We conclude that islet α-cells are functionally heterogenous and that their electrical excitability and glucagon release are determined by K+ channel activity due to variable mosaic of KATP and somatostatin-sensitive K+ channels reflecting metabolic state and proximity to δ-cells, respectively.
| Original language | English |
|---|---|
| Pages (from-to) | 2307-2321 |
| Number of pages | 15 |
| Journal | Diabetes |
| Volume | 74 |
| Issue number | 12 |
| Early online date | 4 Apr 2025 |
| DOIs | |
| Publication status | Published online - 4 Apr 2025 |
Bibliographical note
© 2025 by the American Diabetes Association.Funding
C.M. holds a postdoctoral fellowship from the Swedish Society for Medical Research. Q.Z. held a Diabetes UK RD Lawrence Fellowship during the initial stages of the project. This work was supported by Research Council UK, Medical Research Council (MR/VO11979/1), The Leona M. and Harry B. Helmsley Charitable Trust (G-1912-03553 and G-2305-06047), Swedish Research Council (2013-7107), and Diabetes Research and Wellness Sweden (DWS-2023-0042 PG).
Keywords
- Glucagon-Secreting Cells/metabolism
- Animals
- Glucagon/metabolism
- Paracrine Communication/physiology
- KATP Channels/metabolism
- Mice
- Somatostatin/metabolism
- Action Potentials/drug effects
- Glucose/metabolism
- Amino Acids/pharmacology